Could gene edits solve obstacles to treatment for the most common types of cancer?
Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to treat patients with blood cancers such as leukemia. But when it comes to treating solid tumor cancers, ...
Apr 10, 2026
0
9









